Rotarex™S Case from Leipzig

Case 1

81-year-old female patient with symptomatic Peripheral Arterial Occlusive Disease. Left side, the walking capacity is 30 meters, slowly increasing over six months.

Challenges in treating mixed morphology SFA lesions?

A 63-year-old male patient with intermittent claudication, Rutherford Category 3, prior STEMI 1 month ago, hypertension, hyperlipidemia and current smoker was referred to Prof. Christos Rammos. In the following clinical case study, do a deep dive into how Prof. Rammos used the Rotarex™S Rotational Atherothrombectomy System, Ultrascore™ Focused Force PTA Balloon and Lutonix™ Drug Coated Balloon Catheter to overcome challenges in treating mixed morphology SFA lesions.

Their patient had this condition

Migliara discusses what treatment options are available for CLTI patients and why he chooses Rotarex (BD) when taking an endovascular approach. Local thrombolysis has become an alternative treatment for these types of patients but is “too slow” to restore the flow in the case of a really acute ischaemia and also is “not effective” in cases of subacute or chronic bypass occlusion, he says, adding that “the reason why we have started to use Rotarex S in this type of patient” is because, due to its design, “we are able to obtain very quickly, flow restoration without the use of a lytic agent”.